• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES LLC EDWARDS INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES LLC EDWARDS INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 11500A
Device Problem Gradient Increase (1270)
Patient Problem Insufficient Information (4580)
Event Date 08/03/2023
Event Type  Injury  
Event Description
It was reported a patient with a 25mm 11500a valve implanted in the aortic position developed a high gradient after an implant duration of approximately three years, eight months.The patient was placed back on doac medication for 8 weeks and will repeat tte at that time.Per information received: the patient doing well for three years on doac medications post avr.The patient stopped doac medications.The patient was off anticoagulation for the past 6 to 7 months.Doac medication restarted for 8 weeks and then repeat tte to see if gradients go down.If gradients do not decrease after restarting doac, be considered for viv.Not positive this is as; may be possibly laminated thrombus that developed while off anticoagulation past 6-7 months.Additional information received indicates that the patient underwent a tavr procedure and received a 26mm 9750tfx transcatheter valve.
 
Manufacturer Narrative
H10: additional manufacturer narrative: the subject device is not available for evaluation, as it remains implanted in the patient.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Manufacturer Narrative
The device history record (dhr) review was completed, and this device passed all manufacturing and sterilization inspections prior to release for distribution.There were no issues identified that would have impacted this event.Engineering evaluation summary: high gradients can occur early or late in the lifetime of a prosthetic valve.When it occurs early after valve replacement, it is typically a result of pressure recovery, patient-prosthesis mismatch, and/or sub-valvular or supravalvular obstruction.Measurement error, a high-flow state, prosthesis dysfunction, and pannus overgrowth can cause late high gradients after aortic valve replacement.Prosthesis dysfunction is most likely related to patient/procedural factors, and not to manufacturing non-conformances, which most likely would be identified intraoperatively or early post implant.A definitive root cause cannot be conclusively determined; however, patient and factors likely caused or contributed.All pertinent information available to edwards lifesciences has been submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS INSPIRIS RESILIA AORTIC VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
EDWARDS LIFESCIENCES LLC
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES LLC
1 edwards way
irvine CA 92614
Manufacturer Contact
saurav singh
1 edwards way
mle fl2- office m2013
irvine, CA 92614
9492506615
MDR Report Key17674463
MDR Text Key322596973
Report Number2015691-2023-15694
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00690103194999
UDI-Public(01)00690103194999(17)210702
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/01/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/02/2021
Device Model Number11500A
Device Catalogue NumberN/A
Device Lot NumberN/A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received08/31/2023
Date Device Manufactured07/03/2019
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Life Threatening; Hospitalization;
Patient Age68 YR
Patient SexMale
-
-